Marzena Olesińska

11PUBLICATIONS
27CO-AUTHORS
AllergyNanomedicineMolecular targetsToxicology (incl. clinical toxicology)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 18, 2026
Favorable clinical outcomes of biologic and targeted therapies in refractory eosinophilic fasciitis: a case-based systematic review.

|May 13, 2026
Redefining Difficult-to-Treat Systemic Lupus Erythematosus: Biomarkers of Molecular Refractoriness Beyond Clinical Failure.

|Feb 27, 2026
Kidney-Lung Crosstalk in Acute Nephrologic Involvement: Mechanisms, Complement Activation, and Implications for Multiorgan Dysfunction.

Giuliana Martino, Francesca Tinti, Marco Alfonso Perrone

|Jul 29, 2025
Damage Burden in Polish Patients with Antiphospholipid Syndrome Measured Using Damage Index for Antiphospholipid Syndrome (DIAPS).

Ewa Haladyj, Barbara Stypinska, Agata Matusiewicz

|Oct 09, 2024
Health-related quality of life impairment is equal for antiphospholipid syndrome whether primary or associated with systemic lupus erythematosus.

Ewa Haladyj, Agata Matusiewicz, Tomasz Wysocki

|May 14, 2024
The failure of biological treatment in axial spondyloarthritis is linked to the factors related to increased intestinal permeability and dysbiosis: prospective observational cohort study.

Magdalena Chmielińska, Anna Felis-Giemza, Marzena Olesińska

Pageof 2

Frequent Collaborators

4 joint publications

Agnieszka Paradowska-Gorycka

3 joint publications

Anna Felis-Giemza

3 joint publications

Agata Matusiewicz

2 joint publications

Anna Wajda